| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.30e-04 | 231 | 29 | 4 | GO:0005085 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 9.23e-04 | 31 | 29 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.45e-03 | 343 | 29 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.48e-03 | 51 | 29 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.15e-03 | 459 | 29 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 5.90e-03 | 507 | 29 | 4 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 5.90e-03 | 507 | 29 | 4 | GO:0060589 | |
| GeneOntologyMolecularFunction | channel activity | 6.66e-03 | 525 | 29 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.70e-03 | 526 | 29 | 4 | GO:0022803 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 3.09e-05 | 670 | 29 | 7 | GO:0120031 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 3.56e-05 | 685 | 29 | 7 | GO:0030031 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 5.79e-05 | 302 | 29 | 5 | GO:0022604 | |
| GeneOntologyBiologicalProcess | regulation of cell shape | 6.95e-05 | 159 | 29 | 4 | GO:0008360 | |
| GeneOntologyBiologicalProcess | filopodium assembly | 1.77e-04 | 78 | 29 | 3 | GO:0046847 | |
| GeneOntologyCellularComponent | lamellipodium | 2.73e-04 | 230 | 29 | 4 | GO:0030027 | |
| Domain | RhoGEF | 3.56e-06 | 68 | 29 | 4 | SM00325 | |
| Domain | DH_2 | 4.00e-06 | 70 | 29 | 4 | PS50010 | |
| Domain | RhoGEF | 4.00e-06 | 70 | 29 | 4 | PF00621 | |
| Domain | DH-domain | 4.24e-06 | 71 | 29 | 4 | IPR000219 | |
| Domain | - | 4.24e-06 | 71 | 29 | 4 | 1.20.900.10 | |
| Domain | FYVE | 1.20e-05 | 29 | 29 | 3 | PF01363 | |
| Domain | FYVE | 1.20e-05 | 29 | 29 | 3 | SM00064 | |
| Domain | Znf_FYVE-rel | 1.95e-05 | 34 | 29 | 3 | IPR017455 | |
| Domain | PH | 2.48e-05 | 229 | 29 | 5 | PF00169 | |
| Domain | Znf_FYVE | 2.74e-05 | 38 | 29 | 3 | IPR000306 | |
| Domain | ZF_FYVE | 3.20e-05 | 40 | 29 | 3 | PS50178 | |
| Domain | PH | 6.25e-05 | 278 | 29 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 6.35e-05 | 279 | 29 | 5 | PS50003 | |
| Domain | PH_domain | 6.46e-05 | 280 | 29 | 5 | IPR001849 | |
| Domain | - | 3.08e-04 | 391 | 29 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 4.56e-04 | 426 | 29 | 5 | IPR011993 | |
| Domain | Znf_FYVE_PHD | 1.50e-03 | 147 | 29 | 3 | IPR011011 | |
| Domain | GDS_CDC24_CS | 1.66e-03 | 39 | 29 | 2 | IPR001331 | |
| Domain | DH_1 | 4.29e-03 | 63 | 29 | 2 | PS00741 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 18363964 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 10721717 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 17564959 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 2.42e-05 | 719 | 29 | 6 | 35337019 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 4.63e-04 | 38 | 29 | 2 | 11756498 | |
| Pubmed | 5.93e-04 | 43 | 29 | 2 | 12376548 | ||
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.25e-07 | 66 | 21 | 4 | 722 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.21e-06 | 206 | 21 | 5 | 682 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.94e-06 | 31 | 21 | 3 | 81 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.09e-06 | 199 | 29 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 145 | 29 | 3 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 145 | 29 | 3 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 155 | 29 | 3 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-04 | 165 | 29 | 3 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 166 | 29 | 3 | 417cfb207da08fa1a0fd5f2a13c8786628667a8e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 166 | 29 | 3 | 063d68f2ffb40770cb4601fa1cb6426ae26f7a37 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 166 | 29 | 3 | f28d07715e6b00ca2a0df39273c5f569744be5a8 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 167 | 29 | 3 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-04 | 173 | 29 | 3 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | ASK452-Immune-B_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.93e-04 | 174 | 29 | 3 | 69723f5666abc3af5f0431901a60246c9915ef81 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 179 | 29 | 3 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-04 | 189 | 29 | 3 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 191 | 29 | 3 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.82e-04 | 198 | 29 | 3 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 200 | 29 | 3 | f611335436bb74d22496f7872dff2110c3d3061f | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 7cea58e2691564e653cc972bf5aaff2df1f2666e | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 8444ae3c10b1152dec67ca812e6c417cc3b9cf89 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 193c42c31a366a60d80c4c1fc6a1592a5b01a3ad | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 7c780e995a5fc3793080da61b6bf7a12880e9df8 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)----L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | d0b31dc5eedc0635c0d7ceabaa6202386cf2a4a4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 200 | 29 | 3 | 83afe771e9041c98703d8bad928a98cde601b704 | |
| Drug | 4-nitropyridine | 9.38e-06 | 4 | 29 | 2 | CID000070734 | |
| Disease | Charcot-Marie-Tooth disease type 4H (implicated_via_orthology) | 4.83e-06 | 4 | 27 | 2 | DOID:0110192 (implicated_via_orthology) | |
| Disease | X-linked Aarskog syndrome (implicated_via_orthology) | 4.83e-06 | 4 | 27 | 2 | DOID:6683 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.20e-04 | 24 | 27 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | chronic lymphocytic leukemia | 5.30e-03 | 119 | 27 | 2 | EFO_0000095 | |
| Disease | melanoma | 5.92e-03 | 126 | 27 | 2 | EFO_0000756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLRDPNLQKRYPLAL | 161 | O14734 | |
| SILYRVLPIQKYLEP | 141 | Q6ZPD9 | |
| SQYYPKLRVDIRPQL | 286 | Q5SSJ5 | |
| PSYKRQLRIYLVSLP | 306 | Q9NW15 | |
| VEYALKAQPLRRYIP | 1161 | O60840 | |
| NYLRAEILYRLKIPP | 176 | Q96FI4 | |
| PLYVLKYLRRKLSPP | 1126 | O43861 | |
| PVNKLLYAREIPRYK | 1806 | Q9ULL4 | |
| LLILPLPFLLKRFQY | 156 | Q8NGK1 | |
| RYIKPVPGLLLREYL | 46 | Q8NEN9 | |
| LKYQPLKRSLRQYRP | 781 | Q5T7B8 | |
| PVQRVPRYELLLKDY | 296 | Q5JSP0 | |
| PRYELLLKDYLKRLP | 301 | Q5JSP0 | |
| IVPLRAYYRPKKELN | 736 | Q6UVM3 | |
| AYYRPKKELNPIVLL | 741 | Q6UVM3 | |
| VLRLPKQQLRKLLYP | 36 | Q8N3Z3 | |
| QYPIIYDIRARPRKI | 76 | Q99623 | |
| VPGLLYLLQRQYIPV | 201 | Q9H490 | |
| YILKRQLYENKPRRP | 146 | P30990 | |
| QLYENKPRRPYILKR | 151 | P30990 | |
| VPLQRLLAYPKLNRL | 341 | Q5T8I9 | |
| VYRQRLYELLILLPP | 666 | Q86XA9 | |
| YLPLNTFLLKPIQRL | 671 | O94887 | |
| LQVPQLYKIKRYQPF | 576 | Q4G0U5 | |
| PIRYILLPRIIEAKY | 851 | Q8NBS3 | |
| RQYKPLSLNRLQYLI | 91 | Q9P015 | |
| ENQKYRVYVVIPLLP | 811 | Q13393 | |
| PVQRIPRYELLLKDY | 516 | P98174 | |
| YKPYQIRILDPFIIR | 221 | Q9Y274 | |
| RVPLLEILKYPYLLL | 111 | Q7Z333 | |
| YLLKPVQRIPQYRLL | 1011 | Q6ZV73 | |
| YPPLEGNLYRKLLLI | 1566 | Q8N9V7 |